Characteristics and treatment options of 272,152 geriatric patients with very high and high fracture risk
Osteoporosis International · 2025
DOI: 10.1007/s00198-025-07540-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Osteoporosis International, 2025. Verfasst von Michaela Rippl und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine IV, LMU University Hospital, LMU Munich, Ziemssenstr. 1, 80336, Munich, Germany. michaela.rippl@med.uni-muenchen.de. Hauptthemen laut MEDLINE: Osteoporotic Fractures, Bone Density Conservation Agents, Osteoporosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Klinikum der Universität München.
Abstract (Originalsprache)
Our study of 272,152 geriatric patients assessed osteoporosis treatment requirement and eligibility. Over 75% qualified for therapy, with 54% at very high fracture risk, classifying for bone anabolic treatment. Despite contraindications in 8-20%, most were suitable for treatment. Especially in geriatric patients, early risk-assessment and timely intervention are essential. PURPOSE: The German osteoporosis guideline defines high and very high fracture-risk based on quantifiable evidence-based risk-factors, recommending bone anabolic treatment as first-line therapy for the latter. Given age as a major risk factor, we investigated the proportion of geriatric patients with very high fracture risk, their characteristics, and the percentage suitable for bone anabolic treatment considering contraindications. METHODS: Data from the Geriatrics in Bavaria-Database (GiB-DAT, Geriatrie in Bayern Datenbank) included 272,152 participants (mean age 82 ± 7 years) between 2013 and 2023. Risk-factors and contraindications were evaluated using ICD-10- (International Statistical Classification of Diseases) and ATC-codes (Anatomical Therapeutical Chemical Classification). We analyzed the proportion in the high-risk and very high-risk group, their characteristics, and the share with a contraindication for specific anti-osteoporotic treatments. RESULTS: > 75% of the patients qualified for specific anti-osteoporotic treatment, with the majority (54%) at very high-risk requiring bone anabolic treatment. Patients in the very high-risk group had the lowest mini mental status examination (MMSE) (23 ± 5 points) and activities of daily living (ADL) scores (45 ± 20 points). Contraindications for bone anabolic treatments were found in 20% of women and 8% of all very high-risk patients. Seventy percent of the total study population had no contraindication for any specific anti-osteoporotic medications. CONCLUSION: The majority of geriatric patients is at a very high-risk for osteoporotic fractures, characterized by cognitive impairment, ADL limitations, and increased vulnerability. While some patients had contraindications, most were eligible for anti-osteoporotic and particularly bone anabolic treatments. Timely risk-assessment and treatment initiation is crucial and barriers need to be addressed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine IV, LMU University Hospital, LMU Munich, Ziemssenstr. 1, 80336, Munich, Germany. michaela.rippl@med.uni-muenchen.de.
- Department of Medicine IV, LMU University Hospital, LMU Munich, Ziemssenstr. 1, 80336, Munich, Germany.
- Geriatrie in Bayern-Datenbank (GiB-DAT), Wettinerstr. 4a, 90475, Nuremberg, Germany.
Förderung
- Klinikum der Universität München
Zitieren
APA
Rippl, M., Grupp, P., Martini, S., Müller, K., Schluessel, S., Schmidmaier, R., Tausendfreund, O., Tümena, T., & Drey, M. (2025). Characteristics and treatment options of 272,152 geriatric patients with very high and high fracture risk. Osteoporosis International. https://doi.org/10.1007/s00198-025-07540-y
Vancouver
Rippl M, Grupp P, Martini S, Müller K, Schluessel S, Schmidmaier R, et al. Characteristics and treatment options of 272,152 geriatric patients with very high and high fracture risk. Osteoporosis International. 2025. doi:10.1007/s00198-025-07540-y
BibTeX
@article{Rippl2025,
author = {Rippl, Michaela and Grupp, Pauline and Martini, Sebastian and Müller, Katharina and Schluessel, Sabine and Schmidmaier, Ralf and Tausendfreund, Olivia and Tümena, Thomas and Drey, Michael},
title = {Characteristics and treatment options of 272,152 geriatric patients with very high and high fracture risk},
journal = {Osteoporosis International},
year = {2025},
doi = {10.1007/s00198-025-07540-y}
}
EUVIMED